Article
Targeting the Src pathway enhances the efficacy of selective FGFR inhibitors in cancers…
bioRxiv · 2020 · Nadia Carvalho Lima
Key facts
| Title | Targeting the Src pathway enhances the efficacy of selective FGFR inhibitors in cancers with FGFR3 alterations |
|---|---|
| First author | Nadia Carvalho Lima |
| Journal | bioRxiv |
| Published | Apr 5, 2020 |
| DOI | 10.1101/2020.04.04.025544 |
| Devices mentioned | BK110039 |
| Product codes mentioned | KIT, MVU, NDS, NJT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1